Blog

Motilent & Partners Receive Prestigious UKRI Funding

Motilent & Partners Receive Prestigious UKRI Funding

Crohn’s Disease is a chronic inflammatory condition of the intestine affecting people of all ages. There is an urgent need for technology to guide the use of powerful and expensive anti-inflammatory medications. Motilent has been awarded  a prestigious UKRI grant to...

read more
P4: Little Boats Consortium for Covid-19 Testing

P4: Little Boats Consortium for Covid-19 Testing

As the Covid-19 pandemic escalated in March of this year, the scientific community mobilised to support national efforts to understand and contain the virus. At P4 Precision Medicine Accelerator, we brought together academic institutions, private companies and leading...

read more
My Personal Therapeutics Opens up new lab to fight cancer

My Personal Therapeutics Opens up new lab to fight cancer

My Personal Therapeutics (MPT) are thrilled to be moving into their new drug-screening facility in The West Works, White City Place (https://whitecityplace.com). The space is currently being outfitted with a state of the art facility allowing them to ramp up capacity...

read more
Motilent appoints Laurence Bourn as Chief Technical Officer

Motilent appoints Laurence Bourn as Chief Technical Officer

We are delighted to announce that Laurence Bourn has joined the Motilent team as Chief Technical Officer. Laurence started working with Motilent in August 2019 and will lead the growth of the Company’s technical operations as it enters the clinic. Laurence has 20...

read more
Vinehealth raise £1.2m

Vinehealth raise £1.2m

Dr Rayna Patel, Co-Founder & CEO, is a medical doctor & neuroscientist (Cambridge, Harvard, MIT, Columbia). She graduated top of her year from Medicine at Cambridge, and later returned there to complete a GSK-funded MPhil in Translational Medicine (i.e....

read more
Launch of P4

Launch of P4

Why, Who and When The P4 Precision Medicine Accelerator led by the Institute for Precision Medicine in collaboration with Capital Enterprise was created due to the observations of Professor Phil Beales and Nathan McNally. Phil believes that precision medicine and...

read more